Clinical trials

  • DOMVANALIMAB for Neuroendocrine carcinoma (gastro-enteropancreatic or unknown primary)
  • TECLISTAMAB for Multiple myeloma | Relapsed/refractory multiple myeloma
  • Adeno-associated virus vector serotype 8 encoding the ABCA4 protein (N-region and C-region) for Stargardt disease
  • CLADRIBINE for Multiple sclerosis
  • POVETACICEPT for Primary membranous nephropathy|Membranous nephropathy
  • semaglutide for Type 1 diabetes
  • Ropivacaine hydrochloride for Renal cancer
  • CANGRELOR for Ischemic stroke with intracranial large vessel occlusion (anterior circulation)
  • ALDESLEUKIN for Systemic lupus erythematosus | Systemic sclerosis | Idiopathic inflammatory myositis
  • ECUBECTEDIN for Soft tissue sarcoma|Other solid tumors
  • CEFTRIAXONE for Respiratory tract infections | Bacterial pneumonia | Tracheobronchitis | Reduced level of consciousness (coma states)
  • Aprotinin; Human fibrinogen; Calcium chloride dihydrate; Human thrombin; Human coagulation factor XIII for Gastric cancer | Esophagojejunal anastomotic dehiscence